Access Bio, Inc. (KOSDAQ:950130)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,525.00
-70.00 (-2.70%)
Jun 11, 2026, 3:10 PM KST

Access Bio Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
296,113323,342342,245277,607473,199199,083
Short-Term Investments
46.4542.7650,10511,19813,8791,250
Trading Asset Securities
80,29979,61362,49758,17111,636-
Cash & Short-Term Investments
376,459402,997454,847346,976498,714200,333
Cash Growth
-14.62%-11.40%31.09%-30.43%148.94%297.89%
Accounts Receivable
3,3732,4417,63317,78391,22154,643
Other Receivables
2,0751,5671,6043,8791,0841,081
Receivables
20,4794,01010,14722,04692,32256,379
Inventory
11,47310,71823,46032,224114,17054,477
Prepaid Expenses
353.42441.94599.13790.421,251869.97
Other Current Assets
11,87815,10511,19016,3969,28716,132
Total Current Assets
420,642433,272500,243418,433715,744328,190
Property, Plant & Equipment
55,95356,289137,180139,506130,54780,586
Long-Term Investments
81,17261,55961,673100,9814,0000
Other Intangible Assets
753.2599.96237.86386.73445.95522.29
Long-Term Deferred Tax Assets
57,87451,63932,59925,81927,98924,139
Long-Term Deferred Charges
104.99119.1395.72816.281,0251,196
Other Long-Term Assets
4,6844,5918,1504,7055,7237,361
Total Assets
621,555607,940740,851691,136885,480442,009
Accounts Payable
2,246612.831,1513,4592,1969,737
Accrued Expenses
1,7221,62413,87914,375156,87422,221
Short-Term Debt
---8,9638,88456,142
Current Portion of Long-Term Debt
14,54014,57014,690120120-
Current Portion of Leases
3,9143,6985,4044,3443,9751,932
Current Income Taxes Payable
552.21523.86502.78-8,64714,668
Current Unearned Revenue
2.34-49.8199.32--
Other Current Liabilities
1,9743,8384,72712,65815,60933,551
Total Current Liabilities
24,95024,86640,40344,017196,304138,250
Long-Term Debt
---14,69014,810-
Long-Term Leases
25,24924,57745,90645,02447,63212,008
Long-Term Unearned Revenue
43.61---635.8594.76
Long-Term Deferred Tax Liabilities
21.697.792,137264.05--
Other Long-Term Liabilities
-00--01,110
Total Liabilities
50,26449,45188,446103,995259,382151,962
Common Stock
2,8752,7262,7922,3622,3182,168
Additional Paid-In Capital
75,62271,69972,77354,21765,70461,451
Retained Earnings
570,988548,840647,142567,965590,149233,950
Treasury Stock
-42,117-39,933-40,909-35,883-32,943-4,570
Comprehensive Income & Other
-37,253-26,142-31,646-4,504-7,115-6,409
Total Common Equity
570,114557,190650,152584,155618,112286,590
Minority Interest
1,1771,2992,2532,9867,9863,457
Shareholders' Equity
571,291558,489652,405587,141626,098290,047
Total Liabilities & Equity
621,555607,940740,851691,136885,480442,009
Total Debt
43,70342,84466,00073,14175,42170,081
Net Cash (Debt)
332,756360,153388,847273,835423,293130,251
Net Cash Growth
-11.74%-7.38%42.00%-35.31%224.98%4128.83%
Net Cash Per Share
9458.4310227.6515662.318105.0811183.973491.51
Filing Date Shares Outstanding
34.6735.9835.1733.8133.9635.6
Total Common Shares Outstanding
34.6735.9835.1733.8133.9635.6
Working Capital
395,692408,405459,840374,416519,440189,940
Book Value Per Share
16445.6215486.2018483.9717276.6418199.048049.82
Tangible Book Value
569,361557,091649,914583,768617,666286,067
Tangible Book Value Per Share
16423.8915483.4218477.2117265.2018185.918035.15
Land
--4,2854,2854,2854,161
Buildings
--14,80814,80712,40212,302
Machinery
--89,71576,94948,90625,801
Construction In Progress
--4,1556,69628,74632,495